Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
ED ›
EDOLYNX
Trademark search for:
EDOLYNX
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2017-11-04 — Application filed
2017-11-08 — Application filed
2017-11-14 — Application filed
2017-12-06 — Assigned to examiner
2017-12-07 — Final disposition recorded
2017-12-07 — Final disposition recorded
2017-12-07 — Final disposition recorded
2018-05-24 — Office action issued
2018-05-24 — Correspondence received in law office
2018-05-24 — Teas/email correspondence entered
2018-06-11 — Approved for pub - principal register
2018-06-27 — Notification of notice of publication e-mailed
2018-07-17 — Published for opposition
2018-07-17 — Official gazette publication confirmation e-mailed
2018-09-11 — Noa e-mailed - sou required from applicant
2019-03-08 — Sou teas extension received
2019-03-08 — Sou extension 1 filed
2019-03-08 — Sou extension 1 granted
2019-03-12 — Notice of approval of extension request e-mailed
2019-09-06 — Sou teas extension received
2019-09-06 — Sou extension 2 filed
2019-09-06 — Sou extension 2 granted
2019-09-10 — Notice of approval of extension request e-mailed
2020-01-28 — Sou teas extension received
2020-01-28 — Sou extension 3 filed
2020-01-28 — Sou extension 3 granted
2020-01-30 — Notice of approval of extension request e-mailed
2020-08-12 — Sou teas extension received
2020-08-12 — Sou extension 4 filed
2020-08-12 — Sou extension 4 granted
2020-08-14 — Notice of approval of extension request e-mailed
2021-02-02 — Sou teas extension received
2021-02-02 — Sou extension 5 filed
2021-02-17 — Case assigned to intent to use paralegal
2021-03-08 — Case assigned to intent to use paralegal
2021-03-09 — Sou extension 5 granted
2021-03-10 — Notice of approval of extension request e-mailed
2021-10-18 — Application abandoned
2021-10-18 — Application abandoned
2021-10-18 — Final status recorded
Owner Information
Glaxo Group Limited
Glaxo Group Limited
Correspondent
Christopher M. Hanes GLAXOSMITHKLINE
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
